| Overview |
| bs-6378R-Cy5.5 |
| EID3 Polyclonal Antibody, Cy5.5 Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human, Mouse, Rat, Dog, Cow, Sheep, Horse |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human EID3 |
| 65-160/333 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 493861 |
| Cytoplasm, Nucleus |
| E1A-like inhibitor of dferentiation 3; EID 3; EID-1-like inhibitor of dferentiation 3; EID-3; EID3; EID3_HUMAN; EP300 interacting inhibitor of dferentiation 3; EP300-interacting inhibitor of dferentiation 3; Non-SMC element 4, S. cerevisiae, homolog of, B; NSE4B; NSMCE4B. |
| Act as a repressor of nuclear receptor-dependent transcription possibly by interfering with CREBBP-dependent coactivation. May function as a coinhibitor of other CREBBP/EP300-dependent transcription factors.Tissue specificity: Highly expressed in testis. |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz